Riktkurs.nu
EN | SV
CalliditasMid CapCellavision
Stockholm Stock Exchange | Mid Cap
Camurus
+25.61%
Latest
+13.72%
3 months
DNBNordea MarketsCarnegiePareto SecuritiesJefferiesHandelsbankenDNB Markets

Price Targets For Camurus

AnalystPrice TargetDateUpside
DNB310 SEKSep 9
+25.61%
Nordea Markets270 SEKSep 7
Carnegie262 SEKJul 18
Pareto Securities290 SEKJul 1
Jefferies205 SEKApr 4
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2022